The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II trial of bevacizumab in patients with recurrent solid tumor brain metastases who have failed whole brain radiation therapy (WBRT).
 
Priya Kumthekar
Leadership - Vivacitas Oncology
Stock and Other Ownership Interests - Vivacitas Oncology
Consulting or Advisory Role - Abbvie
Research Funding - Abbvie; DNAtrix; Genentech/Roche; Novocure; Orbus Therapeutics
Patents, Royalties, Other Intellectual Property - Utility patent for ANG 1005. No financial gain, no royalties.
 
Karan Dixit
No Relationships to Disclose
 
Sean Aaron Grimm
No Relationships to Disclose
 
Rimas Vincas Lukas
No Relationships to Disclose
 
Margaret A. Schwartz
No Relationships to Disclose
 
Alfred Rademaker
Research Funding - Siemens (Inst)
Other Relationship - Georgetown Univ.; JAMA-Journal of the American Medical Association
 
Laura Sharp
No Relationships to Disclose
 
Valerie Nelson
Consulting or Advisory Role - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
 
Jeffrey J. Raizer
Employment - Agenus; Astellas Pharma; Celldex
Stock and Other Ownership Interests - Agenus; Cancer Action Now; Celldex; Exicure
Honoraria - ZIOPHARM Oncology
Consulting or Advisory Role - ZIOPHARM Oncology
Research Funding - AstraZeneca/MedImmune; Genentech/Roche; Merck; Novartis; Plexxikon; Stemline Therapeutics